Institutional investors purchased a net $3.0 million shares of DEPO during the quarter ended March 2016 and now own 111.51% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONSONANCE CAPITAL MANAGEMENT LP Bought 2.8 Million shares of Depomed Inc
STARBOARD VALUE LP Bought 2.7 Million shares of Depomed Inc
POINT72 ASSET MANAGEMENT LP Bought 1.9 Million shares of Depomed Inc